Compounds > buthionine sulfoximine
Page last updated: 2024-08-22

buthionine sulfoximine and Leukemia, Myeloid

buthionine sulfoximine has been researched along with Leukemia, Myeloid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karmahapatra, S; Kientz, C; Rakotondraibe, LH; Shetty, S; Yalowich, JC1
Adjei, AA; Bone, N; Bruzek, LM; Chandra, J; Hackbarth, J; Karp, JE; Kaufmann, SH; Kay, NE; Le, S; Loegering, D; Narayanan, VL; Sausville, EA; Tefferi, A1
Chow, J; Huang, M; Lee, C; Lin, C; Lin, Y; Liu, C; Liu, HE1
Lafuente, A; Li, Y; Trush, MA1
Crook, TR; McLean, AE; Souhami, RL; Whyman, GD1

Other Studies

5 other study(ies) available for buthionine sulfoximine and Leukemia, Myeloid

ArticleYear
Capsicodendrin from Cinnamosma fragrans Exhibits Antiproliferative and Cytotoxic Activity in Human Leukemia Cells: Modulation by Glutathione.
    Journal of natural products, 2018, 03-23, Volume: 81, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; DNA Damage; Glutathione; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Magnoliopsida; Polycyclic Sesquiterpenes; Sesquiterpenes

2018
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
    Blood, 2003, Dec-15, Volume: 102, Issue:13

    Topics: Acetylcysteine; Adamantane; Antioxidants; Apoptosis; Buthionine Sulfoximine; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Glutathione; Humans; Hydroquinones; K562 Cells; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Quinones; Reactive Oxygen Species; Tumor Stem Cell Assay; Tyrphostins

2003
Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:3

    Topics: Acute Disease; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Buthionine Sulfoximine; Cell Count; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Drug Resistance, Neoplasm; Glutathione; Humans; Injections, Intraperitoneal; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Oxides; Stromal Cells; Treatment Failure

2006
Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity.
    Life sciences, 1994, Volume: 54, Issue:13

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Dicumarol; Drug Synergism; Enzyme Induction; Glutathione; Glutathione Transferase; Humans; Hydroquinones; Leukemia, Myeloid; Methionine Sulfoximine; Models, Chemical; NAD(P)H Dehydrogenase (Quinone); Peroxidase; Thiones; Thiophenes; Tumor Cells, Cultured

1994
Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Cancer research, 1986, Volume: 46, Issue:10

    Topics: Acrolein; Aldehyde Dehydrogenase; Biotransformation; Buthionine Sulfoximine; Cell Line; Cell Survival; Cyclophosphamide; DNA Damage; Glutathione; Humans; Leukemia, Myeloid; Liver; Methionine Sulfoximine; Phosphoramide Mustards

1986